PapersPMID:23161001
Yohimbine increases opioid-seeking behavior in heroin-dependent, buprenorphine-maintained individuals.
- findings
- 2
- compound
- 1
- endpoints
- 2
- Study, every finding
- crossover
- Dose studied, every finding
- yohimbine 16.2 mg and 32.4 mg orally, single dose per session at 9:30 AM, against placebo capsules of lactose
- Population, every finding
- heroin-dependent volunteers not seeking treatment, maintained on buprenorphine 8 mg/day, inpatient; yohimbine 16.2 and 32.4 mg pooled against placebo pretreatment, before any hydromorphone was given on the session
What moved
How to read these marks →“Yohimbine significantly increased systolic blood pressure ≈15 mmHg (η2 = 0.67) and diastolic blood pressure ≈10 mmHg (η2 = 0.61).”
- Interests
- An author is affiliated with a producer
- Interests
- An author is affiliated with a producer
Study record
- Design
- crossover trial
- Species
- human
- Population
- heroin-dependent, buprenorphine-maintained volunteers not seeking treatment
- Participants
- 10
- Comparator
- another dose / placebo
- Duration
- not reported
- Endpoints measured
- 36